Back to first-pass browser

First-pass extracted concept

molecular imaging

Candidate: concept label3 source documents4 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

The abstract lists molecular imaging as a key direction in nanotechnology for ischemic cardiomyopathy.

Source 1DOIPubMed

Molecular imaging is presented as a diagnostic application where nanoparticles act as imaging agents.

Source 2DOIPubMed

This is the overarching field concerned with seeing biological processes in living subjects. In this source it functions as the main review topic rather than a single tool.

Source 3DOIPubMed

What problem it solves

The abstract states that nanoparticle-based molecular imaging can be used to detect and monitor cancer progression.

Source 2DOIPubMed

It frames noninvasive observation of biology in vivo across multiple imaging modalities.

Source 3DOIPubMed

What it does not solve

The available payload does not specify one particular molecular imaging implementation or protocol.

Source 3DOIPubMed

Evidence Snippets

The key directions in this field contain cardiac tissue engineering, biosensor, targeted drug delivery and molecular imaging.
Evidence 1Source 1DOIPubMedprovenance
This review article will discuss how nanoparticles can be used as molecular imaging agents to detect and monitor cancer progression.
Evidence 2Source 2DOIPubMedprovenance
The review title explicitly names 'Molecular imaging in living subjects'.
Evidence 3Source 3DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1topic landscapesupports2026Source 1DOIPubMed

Key directions in nanotechnology for ischemic cardiomyopathy include cardiac tissue engineering, biosensors, targeted drug delivery, and molecular imaging.

Claim 2diagnostic rolesupports2013Source 2DOIPubMed

Nanoparticles can be used as molecular imaging agents to detect and monitor cancer progression.

Quoted textsource-backed
how nanoparticles can be used as molecular imaging agents to detect and monitor cancer progression
Claim 3review scopesupports2003Source 3DOIPubMed

This review covers molecular imaging in living subjects.

Quoted textsource-backed
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
Claim 4topic coveragesupports2003Source 3DOIPubMed

The source-associated summary indicates that the review's technology scope spans PET, MRI, fluorescence microscopy, molecular probe techniques, and small-animal models.

Quoted textsource-backed
PubMed indexes it as a review and assigns MeSH terms spanning reporter genes, PET, MRI, fluorescence microscopy, molecular probe techniques, and small-animal models.